Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.
Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.
Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.
Baricitinib helps treat severe hair loss in people over 65.
Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.
Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.
A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.
Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.
Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.
Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.